Annual Accounts Receivable
$3.80 M
-$2.55 M-40.15%
December 31, 2023
Summary
- As of February 8, 2025, MRNS annual accounts receivable is $3.80 million, with the most recent change of -$2.55 million (-40.15%) on December 31, 2023.
- During the last 3 years, MRNS annual accounts receivable has risen by +$2.15 million (+130.80%).
- MRNS annual accounts receivable is now -40.15% below its all-time high of $6.35 million, reached on December 31, 2022.
Performance
MRNS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$3.84 M
+$405.00 K+11.79%
September 30, 2024
Summary
- As of February 8, 2025, MRNS quarterly accounts receivable is $3.84 million, with the most recent change of +$405.00 thousand (+11.79%) on September 30, 2024.
- Over the past year, MRNS quarterly accounts receivable has stayed the same.
- MRNS quarterly accounts receivable is now -67.16% below its all-time high of $11.69 million, reached on March 31, 2023.
Performance
MRNS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
MRNS Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.1% | 0.0% |
| 3 y3 years | +130.8% | -39.5% |
| 5 y5 years | - | -39.5% |
MRNS Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.1% | +44.5% | -67.2% | +54.3% |
| 5 y | 5-year | -40.1% | -100.0% | -67.2% | -100.0% |
| alltime | all time | -40.1% | -100.0% | -67.2% | -100.0% |
Marinus Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.84 M(+11.8%) |
| Jun 2024 | - | $3.44 M(-2.2%) |
| Mar 2024 | - | $3.51 M(-7.5%) |
| Dec 2023 | $3.80 M(-40.2%) | $3.80 M(-11.3%) |
| Sep 2023 | - | $4.28 M(-18.2%) |
| Jun 2023 | - | $5.23 M(-55.2%) |
| Mar 2023 | - | $11.69 M(+84.2%) |
| Dec 2022 | $6.35 M | $6.35 M(+86.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $3.40 M(+13.3%) |
| Jun 2022 | - | $3.00 M(+20.5%) |
| Mar 2022 | - | $2.49 M(-5.3%) |
| Dec 2021 | $2.63 M(+59.7%) | $2.63 M(+6.3%) |
| Sep 2021 | - | $2.47 M(-41.1%) |
| Jun 2021 | - | $4.20 M(+58.5%) |
| Mar 2021 | - | $2.65 M(+61.0%) |
| Dec 2020 | $1.65 M(>+9900.0%) | $1.65 M(>+9900.0%) |
| Dec 2019 | $0.00 | $0.00 |
FAQ
- What is Marinus Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals annual accounts receivable year-on-year change?
- What is Marinus Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Marinus Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of MRNS is $3.80 M
What is the all time high annual accounts receivable for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high annual accounts receivable is $6.35 M
What is Marinus Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, MRNS annual accounts receivable has changed by -$2.55 M (-40.15%)
What is Marinus Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of MRNS is $3.84 M
What is the all time high quarterly accounts receivable for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high quarterly accounts receivable is $11.69 M
What is Marinus Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, MRNS quarterly accounts receivable has changed by $0.00 (0.00%)